ArticleFrontiers in oncology2023

On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.

Li-Qiong Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.